Multi-target TMS for Schizophrenia Negative Symptoms
RecruitingNCT07559084Phase: NAStarted 2026-05-01
Summary
This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the left dorsolateral prefrontal cortex (L-DLPFC), left inferior parietal lobule (L-IPL), and right orbitofrontal cortex (R-OFC) for negative symptoms of schizophrenia.
Eligibility
Sex
ALL
Min Age
16 Years
Max Age
45 Years
Inclusion Criteria: 1. Outpatients or inpatients at the Department of Psychiatry, Shanghai Mental Health Center; 2. Meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for first-episode schizophrenia (diagnosed using the Structured Clinical Interview for DSM
Locations
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Interested in participating? View the full study details on ClinicalTrials.gov:
View on ClinicalTrials.gov →